Data as of Q4 2025 (Dec 31, 2025)

NEA Management Company, LLC

โ€ขCIK: 1512848โ€ขFiling: Q4 2025

**NEA Management Company, LLC** This $2.0B fund maintains a concentrated portfolio of 27 positions, exhibiting significant conviction in select names. Top holdings are anchored by CELC at $352.6M and RYTM at $311.5M, representing substantial allocations within the current market structure. The remaining portfolio features notable exposure to ACLX ($198.6M) and TRVI ($165.5M). NEA's strategy appears focused on high-conviction, deep-value opportunities across diverse sectors.

Total AUM
$2.0B
QoQ Performance
+7.6%
Positions
27
Top 10 Concentration
86.5%
Latest Filing
Q4 2025

Top Holdings Allocation

CELC
RYTM
ACLX
TRVI
YB4P
ZBIO
GLUE
MBX
CELC18.0%
RYTM15.9%
ACLX10.1%
TRVI8.4%
YB4P7.5%
ZBIO6.5%
GLUE6.2%
MBX5.8%

๐Ÿ“ˆ Biggest Buys

CELC
Celcuity Inc.
+64.9%
18.0% of portfolio
ZBIO
Zenas BioPharma, Inc.
+28.9%
6.5% of portfolio
ASNSUSD
X4 Pharmaceuticals, Inc.
+44.8%
0.7% of portfolio
LONA
LeonaBio, Inc.
NEW
0.2% of portfolio

๐Ÿ“‰ Biggest Sells

No reductions this quarter

Sector Breakdown

Other100.0%

๐Ÿšช Exited Positionssold since Q3 2025

VRNA
VERONA PHARMA PLC
SOLD
$240.4M
โ€”
NEUEHEALTH INC
SOLD
$18.2M
OMDA
OMADA HEALTH INC
SOLD
$8.1M

Changes from Q3 2025

NEW1 new position
โ†‘3 increased

Historical Filings

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023